- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
5
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MEDP | US$337.35 | -4.2% | 12.5% | US$10.5b | US$347.92 | PE28.6x | E10.9% | n/a | ||
PTGX | US$36.82 | -0.9% | 47.3% | US$2.2b | US$57.10 | PE12.8x | E0.9% | n/a | ||
AGIO | US$32.42 | -5.5% | 50.0% | US$1.8b | US$57.00 | PE2.7x | E-29.8% | n/a | ||
MDXG | US$9.12 | 6.5% | 7.7% | US$1.3b | US$13.40 | PE16.9x | E-1.9% | n/a | ||
SCNI | US$3.51 | 2.6% | -37.3% | US$3.0m | n/a | PE0.6x | n/a | n/a |
Page 1 of 1